JPMorgan Chase & Co’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
|
|||||
|
2025
Q1 | $210K | Sell |
|
|||||
|
2024
Q4 | $985K | Buy |
|
|||||
|
2024
Q3 | $1.09M | Sell |
|
|||||
|
2024
Q2 | $13M | Buy |
|
|||||
|
2024
Q1 | $21.6M | Sell |
|
|||||
|
2023
Q4 | $36.2M | Buy |
|
|||||
|
2023
Q3 | $34.3M | Sell |
|
|||||
|
2023
Q2 | $79.6M | Buy |
|
|||||
|
2023
Q1 | $57.7M | Sell |
|
|||||
|
2022
Q4 | $53.9M | Sell |
|
|||||
|
2022
Q3 | $59.9M | Sell |
|
|||||
|
2022
Q2 | $50.1M | Sell |
|
|||||
|
2022
Q1 | $53.4M | Buy |
|
|||||
|
2021
Q4 | $66.4M | Buy |
|
|||||
|
2021
Q3 | $51.6M | Buy |
|
|||||
|
2021
Q2 | $64.9M | Buy |
|
|||||
|
2021
Q1 | $84.5M | Sell |
|
|||||
|
2020
Q4 | $130M | Sell |
|
|||||
|
2020
Q3 | $91.7M | Buy |
|
|||||
|
2020
Q2 | $57.8M | Sell |
|
|||||
|
2020
Q1 | $40.4M | Buy |
|
|||||
|
2019
Q4 | $100M | Buy |
|
|||||
|
2019
Q3 | $129M | Buy |
|
|||||
|
2019
Q2 | $165M | Sell |
|
|||||
|
2019
Q1 | $151M | Buy |
|
|||||
|
2018
Q4 | $91.1M | Buy |
|
|||||
|
2018
Q3 | $132M | Buy |
|
|||||
|
2018
Q2 | $146M | Buy |
|
|||||
|
2018
Q1 | $116M | Sell |
|
|||||
|
2017
Q4 | $130M | Sell |
|
|||||
|
2017
Q3 | $52.7M | Buy |
|
|||||
|
2017
Q2 | $65.2M | Sell |
|
|||||
|
2017
Q1 | $59.3M | Sell |
|
|||||
|
2016
Q4 | $51M | Sell |
|
|||||
|
2016
Q3 | $55.6M | Buy |
|
|||||
|
2016
Q2 | $32.4M | Buy |
|
|||||
|
2016
Q1 | $32.9M | Buy |
|
|||||
|
2015
Q4 | $56.3M | Buy |
|
|||||
|
2015
Q3 | $38.1M | Buy |
|
|||||
|
2015
Q2 | $59.1M | Buy |
|
|||||
|
2015
Q1 | $39.9M | Buy |
|
|||||
|
2014
Q4 | $6.52M | Buy |
|
|||||
|
2014
Q3 | $1.85M | Buy |
|